Acid-cleavable thiomaleamic acid linker for homogeneous antibody-drug conjugation

被引:60
作者
Castaneda, Lourdes [1 ]
Maruani, Antoine [1 ]
Schumacher, Felix F. [1 ]
Miranda, Enrique [2 ]
Chudasama, Vijay [1 ]
Chester, Kerry A. [2 ]
Baker, James R. [1 ]
Smith, Mark E. B. [1 ]
Caddick, Stephen [1 ]
机构
[1] UCL, Dept Chem, London WC1H 0AJ, England
[2] UCL Canc Inst, London WC1E 6BT, England
基金
英国惠康基金; 英国生物技术与生命科学研究理事会; 英国工程与自然科学研究理事会;
关键词
MONOCLONAL-ANTIBODIES; THERAPEUTIC INDEX; BREAST-CANCER; FUTURE; BROMOMALEIMIDES; TRASTUZUMAB; DOXORUBICIN;
D O I
10.1039/c3cc45220d
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
In this communication we describe a novel acid-cleavable linker strategy for antibody-drug conjugation. Functional disulfide bridging of the single interchain disulfide bond of a trastuzumab Fab fragment yields a homogeneous antibody-drug conjugate bearing a thiomaleamic acid linker. This linker is stable at physiological pH and temperature, but quantitatively cleaves at lysosomal pH to release the drug payload.
引用
收藏
页码:8187 / 8189
页数:3
相关论文
共 27 条
[1]   Antibody-drug conjugates - a perfect synergy [J].
Adair, John R. ;
Howard, Philip W. ;
Hartley, John A. ;
Williams, David G. ;
Chester, Kerry A. .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (09) :1191-1206
[2]   Antibody-drug conjugates: targeted drug delivery for cancer [J].
Alley, Stephen C. ;
Okeley, Nicole M. ;
Senter, Peter D. .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2010, 14 (04) :529-537
[3]  
[Anonymous], J CHM SOC P2
[4]   ADRIAMYCIN, 14-HYDROXYDAUNOMYCIN, A NEW ANTITUMOR ANTIBIOTIC FROM S-PEUCETIUS VAR CAESIUS [J].
ARCAMONE, F ;
CASSINEL.G ;
FANTINI, G ;
GREIN, A ;
OREZZI, P ;
POL, C ;
SPALLA, C .
BIOTECHNOLOGY AND BIOENGINEERING, 1969, 11 (06) :1101-&
[5]   Monitoring papain digestion of a monoclonal antibody by electrospray ionization mass spectrometry [J].
Bennett, KL ;
Smith, SV ;
Truscott, RJW ;
Sheil, MM .
ANALYTICAL BIOCHEMISTRY, 1997, 245 (01) :17-27
[6]   A mild synthesis of N-functionalised bromomaleimides, thiomaleimides and bromopyridazinediones [J].
Castaneda, Lourdes ;
Wright, Zoe V. F. ;
Marculescu, Cristina ;
Tran, Trang M. ;
Chudasama, Vijay ;
Maruani, Antoine ;
Hull, Elizabeth A. ;
Nunes, Joao P. M. ;
Fitzmaurice, Richard J. ;
Smith, Mark E. B. ;
Jones, Lyn H. ;
Caddick, Stephen ;
Baker, James R. .
TETRAHEDRON LETTERS, 2013, 54 (27) :3493-3495
[7]   Therapeutic antibodies: successes, limitations and hopes for the future [J].
Chames, Patrick ;
Van Regenmortel, Marc ;
Weiss, Etienne ;
Baty, Daniel .
BRITISH JOURNAL OF PHARMACOLOGY, 2009, 157 (02) :220-233
[8]  
Dimitrov Dimiter S., 2009, V525, P1, DOI 10.1007/978-1-59745-554-1_1
[9]   Cathepsin B-labile dipeptide linkers for lysosomal release of doxorubicin from internalizing immunoconjugates: Model studies of enzymatic drug release and antigen-specific in vitro anticancer activity [J].
Dubowchik, GM ;
Firestone, RA ;
Padilla, L ;
Willner, D ;
Hofstead, SJ ;
Mosure, K ;
Knipe, JO ;
Lasch, SJ ;
Trail, PA .
BIOCONJUGATE CHEMISTRY, 2002, 13 (04) :855-869
[10]   Antibody-Drug Conjugates: Linking Cytotoxic Payloads to Monoclonal Antibodies [J].
Ducry, Laurent ;
Stump, Bernhard .
BIOCONJUGATE CHEMISTRY, 2010, 21 (01) :5-13